{
    "url_original": "https://www.wsj.com/articles/first-big-omicron-study-finds-two-doses-of-pfizers-vaccine-cuts-hospitalization-risk-by-70-11639495432",
    "url": "first-big-omicron-study-finds-two-doses-of-pfizers-vaccine-cuts-hospitalization-risk-by-70-11639495432",
    "title": "Study Finds Two Pfizer Vaccine Doses Offer Less Protection Against Omicron Than Against Delta",
    "sub_head": "Protection against hospitalization falls to 70% from 93% and against infection to 33% from 80%",
    "category_1": "World",
    "time": "2021-12-14 16:50:00",
    "body": "The first large real-world study of how vaccines hold up against Omicron found that two shots of  Pfizer Inc.  and  BioNTech SE ’s  Covid-19 vaccine lowered the risk of hospital admission by 70% for patients infected with the highly mutated variant.<br />The study, by South Africa’s largest private health insurer Discovery Ltd., found that while Omicron reduced vaccine effectiveness against infection to 33% from 80% for Delta, its effect on protection against hospitalization was less marked, falling to 70% from 93%."
}